NEW YORK (Reuters Health) - Close to half of U.S. girls ages 13 and 17 have gotten at least one dose of the vaccine against human papillomavirus (HPV), but there is still a way to go to improve those ...

A pediatric vaccine to help prevent respiratory syncytial virus (RSV), which was introduced for the first time this year, is in short supply. Nirsevimab, trade name Beyfortus, is unlikely to be fully ...

In an effort to prevent a shortage, the U.S. Centers for Disease Control and Prevention is advising doctors to conserve the tetanus vaccine because one manufacturer is stopping production. The vaccine ...

Despite awareness campaigns through schools and health workers, officials cite vaccine hesitancy and misconceptions as key ...

When it comes to measles, the United States has a problem. But it isn’t just a policy problem, it’s a math problem — even if everyone attending in-person school were vaccinated, we’d still fall short.